Exploring Cancer Patients’ and Caregivers’ Perspectives and Knowledge Regarding Biomarker Testing in Canada
Current Oncology · 2025
DOI: 10.3390/curroncol32060292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Patil Mksyartinian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Cancer Canada, Westmount, QC H3Z 2P9, Canada. Hauptthemen laut MEDLINE: Caregivers, Neoplasms, Biomarkers, Tumor, Health Knowledge, Attitudes, Practice. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Colorectal Cancer Canada.
Themen: Onkologische Pflege
Abstract (Originalsprache)
While biomarker testing can provide various benefits for cancer patient outcomes, numerous challenges persist that cause inequities in access across Canada. An online survey consisting of 51 questions was disseminated to evaluate biomarker testing and precision medicine knowledge and experiences from Canadian patients and caregivers. Responses were recorded between June 2023 and January 2024 and assessed various aspects of the biomarker testing experience including the expectations and challenges of patients. Quantitative and qualitative analyses were conducted using Microsoft Excel and R for descriptive and correlative data analysis, respectively. Among the 74 responses, patients reported an overall moderate experience with positive outcomes for those who underwent biomarker testing, including changes to treatment plans and the shrinking of tumours. The main challenges identified included knowledge gaps, a lack of testing availability, turnaround time for results, and financial constraints, all of which contribute to the disparities in biomarker testing access. Qualitative analysis of responses further emphasized a strong patient desire for patient-centred care and collaborative decision-making for biomarker testing options and treatment planning. Addressing these challenges through increased education, policy advocacy, and advancing infrastructure can help to reduce interprovincial inequities in biomarker testing and contribute to improving cancer patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Colorectal Cancer Canada, Westmount, QC H3Z 2P9, Canada.
- School of Public Health Sciences, University of Waterloo, Waterloo, ON N2L 3G1, Canada.
- School of Population and Global Health, McGill University, Montreal, QC H3A 0G4, Canada.
- Ingram School of Nursing (ISoN), McGill University, Montreal, QC H3A 0G4, Canada.
- Research Centre of Sainte-Justine University Hospital (RC-CHUSJ), Montreal, QC H3T 1C5, Canada.
ORCID-Profile: Patil Mksyartinian, Sandra Peláez, Barry D Stein
Förderung
- Colorectal Cancer Canada
Zitieren
APA
Mksyartinian, P., Xu, S., Barroma, C., Peláez, S., & Stein, B. D. (2025). Exploring Cancer Patients’ and Caregivers’ Perspectives and Knowledge Regarding Biomarker Testing in Canada. Current Oncology. https://doi.org/10.3390/curroncol32060292
Vancouver
Mksyartinian P, Xu S, Barroma C, Peláez S, Stein BD. Exploring Cancer Patients’ and Caregivers’ Perspectives and Knowledge Regarding Biomarker Testing in Canada. Current Oncology. 2025. doi:10.3390/curroncol32060292
BibTeX
@article{Mksyartinian2025,
author = {Mksyartinian, Patil and Xu, Selina and Barroma, Chrissa and Peláez, Sandra and Stein, Barry D},
title = {Exploring Cancer Patients’ and Caregivers’ Perspectives and Knowledge Regarding Biomarker Testing in Canada},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32060292}
}
EUVIMED